Answers are grounded in this paper and cite their sources.
Mycobacterium avium complex pulmonary disease (MAC-PD) is a chronic infectious disease characterized by a high rate of recurrence. No previous study has examined the efficacy of traditional Chinese medicine (TCM) on reducing MAC-PD recurrence. Bailing capsule ( Bailing ) is effective in treating chronic bronchitis and chronic obstructive pulmonary disease. Previous studies have proved its immunomodulatory effects and might be effective for preventing the recurrence of MAC-PD. This study is a multi-center, randomized, double-blind, placebo-controlled clinical trial with parallel design. 300 participants with microbiologically cured MAC-PD will be recruited and randomly assigned to either Bailing group or placebo group in a ratio of 1:1. Both Bailing and placebo will be administered 4 capsules, three times per day orally for 12 consecutive months with monthly follow-ups including quality of life questionnaire, blood analysis and radiologic examinations. The primary outcome is the rate of MAC-PD recurrence within 12 months, detected by mycobacteria culture or sequencing. Secondary outcomes include time-to-recurrence, the rate of other respiratory tract infections, quality of life, respiratory symptoms and adverse events. This trial is the first to prospectively evaluate the effect of a specific intervention in reducing the recurrence of MAC-PD. The rigid design and large sample size further boost the power of this trial. Through this study, we hope to establish TCM as a host-directed therapy in the long-term management of chronic infectious disease. Further research will be made to evaluate the optimal duration of treatment. NCT07174076.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: